1. GPCR/G Protein
  2. Cholecystokinin Receptor

Cholecystokinin Receptor

Cholecystokinin (CCK) is a neuropeptide that affects growth rate in chickens by regulating appetite. CCK peptides exert their function by binding to two identified receptors, CCKAR and CCKBR in the GI tract and the brain, respectively, as well as in other organs. In mammals, CCK/CCKAR interactions affect a number of immunological parameters, including regulation of lymphocytes and functioning of monocytes.

CCK, also known as pancreozymin, is synthesized and secreted by enteroendocrine cells in the duodenum. The main function of CCK is to cause the release of digestive enzymes and bile from the pancreas and gallbladder, respectively. It also induces drug tolerance to opioids like morphine and heroin. Cholecystokinin (CCK) has strong bioactivity in the regulation of a number of cell activities.

Cholecystokinin Receptor 相关产品 (5):

Cat. No. Product Name Effect Purity
  • HY-17617
    Nastorazepide Antagonist 99.78%
    Nastorazepide(Z-360)是一种选择性的, 口服有效的, 1,5-苯并二氮杂环衍生物胃泌素/胆囊收缩素2(CCK-2)受体拮抗剂,具有潜在的抗肿瘤活性。
  • HY-B1330
    Proglumide Antagonist 99.74%
    Proglumide 是已知的胆囊收缩素 (CCK) 拮抗剂。
  • HY-U00062
    Tarazepide Antagonist
    Tarazepide 是一种有效且特异性的 CCK-A 受体拮抗剂。
  • HY-B2154
    Loxiglumide Antagonist >98.0%
    Loxiglumide 是缩胆囊素 (CCK-1) 受体拮抗剂。
  • HY-U00375
    Gastrin/CCK antagonist 1 Antagonist
    Gastrin/CCK antagonist 1 是 gastrin/CCK 的拮抗剂,可用于肠胃失调疾病的研究。